PROMIS NEUROSCIENCES INC. Amortization of Intangible Assets
PROMIS NEUROSCIENCES INC. (PMN) reported Amortization of Intangible Assets of $20.84 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-03-31
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for the quarter ending 2023-12-31 was $18.02K, a 1419.56% increase year-over-year.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for the quarter ending 2023-09-30 was $345.00, a 72.68% decline year-over-year.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for the quarter ending 2023-06-30 was $1.24K, a 5.21% decline year-over-year.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for the quarter ending 2023-03-31 was $1.23K, a 6.38% decline year-over-year.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for fiscal 2023 was $20.84K, a 310.84% increase from fiscal 2022.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for fiscal 2022 was $5.07K, a 3.37% decline from fiscal 2021.
- PROMIS NEUROSCIENCES INC. amortization of intangible assets for fiscal 2021 was $5.25K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $18.02K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $18.37K derived: sum of 2 quarters · filed 2025-03-31 | $19.61K derived: sum of 3 quarters · filed 2025-03-31 | $20.84K 10-K · filed 2025-03-31 |
| 2023-09-30 | $345.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.58K derived: sum of 2 quarters · filed 2024-11-14 | $2.82K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.47K 10-Q · filed 2024-08-08 | $3.66K derived: sum of 3 quarters · filed 2024-08-08 | $4.92K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.23K 10-Q · filed 2024-05-14 | $2.42K derived: sum of 2 quarters · filed 2024-05-14 | $3.68K derived: sum of 3 quarters · filed 2024-05-14 | $4.99K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.45K derived: sum of 2 quarters · filed 2024-04-01 | $3.75K derived: sum of 3 quarters · filed 2024-04-01 | $5.07K 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.26K 10-Q · filed 2022-11-14 | $2.57K derived: sum of 2 quarters · filed 2022-11-14 | $3.89K 10-Q · filed 2023-11-14 | $5.18K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-06-30 | $1.31K 10-Q · filed 2022-08-12 | $2.62K 10-Q · filed 2023-08-14 | $3.91K derived: sum of 3 quarters · filed 2023-05-15 | $5.24K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-03-31 | $1.32K 10-Q · filed 2023-05-15 | $2.61K derived: sum of 2 quarters · filed 2023-05-15 | $3.93K derived: sum of 3 quarters · filed 2023-05-15 | $5.25K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.29K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.61K derived: sum of 2 quarters · filed 2023-03-08 | $3.93K derived: sum of 3 quarters · filed 2023-03-08 | $5.25K 10-K · filed 2023-03-08 |
| 2021-09-30 | $1.32K 10-Q · filed 2022-11-14 | $2.64K derived: sum of 2 quarters · filed 2022-11-14 | $3.96K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.32K 10-Q · filed 2022-08-12 | $2.64K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |